Well Referenced

Tag: Adjuvant treatment

Corrigendum to “A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial”

This corrigendum, published in 2022, addresses corrections to the original 2021 pilot study that evaluated intravenous ozonized saline as an adjunctive treatment for moderate COVID-19 cases. While the specific corrections are not detailed in the available abstract, such corrigenda typically involve amendments to data, authorship, or methodological details. The original

Read More »
June 26, 2025 No Comments

Adverse Drug Reactions and Expected Effects to Therapy With Subcutaneous Mistletoe Extracts (Viscum Album L.) in Cancer Patients

This observational study assessed the safety and adverse drug reactions (ADRs) of subcutaneous mistletoe (Viscum album) extract in cancer patients. A total of 1,923 patients receiving mistletoe as part of anthroposophic medicine were observed, with 14.7% reporting expected effects such as local reactions and mild fever. Only 8.4% of patients

Read More »
June 26, 2025 No Comments